Digital quantification of five high-grade prostate cancer patterns, including the cribriform pattern, and their association with adverse outcome
- PMID: 21685037
- PMCID: PMC4656017
- DOI: 10.1309/AJCPZ7WBU9YXSJPE
Digital quantification of five high-grade prostate cancer patterns, including the cribriform pattern, and their association with adverse outcome
Abstract
Proper grading of the cribriform prostate cancer pattern has not previously been supported by outcome-based evidence. Among 153 men who underwent radical prostatectomy, 76 with prostate-specific antigen (PSA) failure (≥0.2 ng/mL [0.2 μg/L]) were matched to 77 without failure. Frequencies of high-grade patterns included fused small acini, 83.7%; papillary, 52.3%; large cribriform, 37.9%; small (≤12 lumens) cribriform, 17.0%; and individual cells, 22.9%. A cribriform pattern was present in 61% (46/76) of failures but 16% (12/77) of nonfailures (P < .0001). Multivariate analysis showed the cribriform pattern had the highest odds ratio for PSA failure, 5.89 (95% confidence interval, 2.53-13.70; P < .0001). The presence of both large and small cribriform patterns was significantly linked to failure. The cumulative odds ratio of failure per added square millimeter of cribriform pattern was 1.173 (P = .008), higher than for any other pattern. All 8 men with a cribriform area sum of 25 mm(2) or more had failure (range, 33-930). Regrading cribriform cancer as Gleason 5 improved the grade association with failure, although half of all cases with individual cells also had a cribriform pattern, precluding a precise determination of the independent importance of the latter. The cribriform pattern has particularly adverse implications for outcome.
Figures


References
-
- Gleason DF. Classification of prostatic carcinomas. Cancer Chemother Rep. 1966;50:125–128. - PubMed
-
- Gleason DF, Mellinger GT and the VA Cooperative Urological Research Group. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol. 1974;111:58–64. - PubMed
-
- Gleason DF. Histologic grading of prostate cancer: a perspective. Hum Pathol. 1992;23:273–279. - PubMed
-
- Berney DM. Low Gleason score prostatic adenocarcinomas are no longer viable entities. Histopathology. 2007;50:683–690. - PubMed
-
- Epstein JI. Gleason score 2–4 adenocarcinoma of the prostate on needle biopsy: a diagnosis that should not be made [editorial] Am J Surg Pathol. 2000;24:477–478. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous